Inhibitor Therapeutics, Inc. financial data

Symbol
INTI on OTC
Location
4830 W. Kennedy Blvd., Suite 600, Tampa, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.65K % -51.1%
Debt-to-equity 325 % +340%
Return On Equity -338 % -378%
Return On Assets -79.5 % -95.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 173M shares +0.15%
Common Stock, Shares, Outstanding 173M shares +0.15%
Entity Public Float 6.6M USD +106%
Common Stock, Value, Issued 17.3K USD +0.15%
Weighted Average Number of Shares Outstanding, Basic 173M shares +0.15%
Weighted Average Number of Shares Outstanding, Diluted 173M shares +0.15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.75M USD +12.7%
General and Administrative Expense 1.84M USD -2.55%
Operating Income (Loss) -3.6M USD -4.33%
Net Income (Loss) Attributable to Parent -3.43M USD -11.1%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.98M USD -53.3%
Assets, Current 3.06M USD -52.5%
Operating Lease, Right-of-Use Asset 71.1K USD
Assets 3.14M USD -51.4%
Accounts Payable, Current 19.6K USD +1052%
Accrued Liabilities, Current 40.4K USD -5.65%
Liabilities, Current 87.5K USD +96.4%
Long-term Debt and Lease Obligation 44.2K USD
Liabilities 3.13M USD +2.86%
Retained Earnings (Accumulated Deficit) -54.1M USD -6.76%
Stockholders' Equity Attributable to Parent 716K USD -82.7%
Liabilities and Equity 3.14M USD -51.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.28M USD -11%
Net Cash Provided by (Used in) Financing Activities -411K USD -922%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 173M shares +0.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.28M USD -11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.98M USD -53.3%
Deferred Tax Assets, Valuation Allowance 6.29M USD +15.4%
Deferred Tax Assets, Gross 6.29M USD +15.4%
Operating Lease, Liability 71.6K USD
Lessee, Operating Lease, Liability, to be Paid 78.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 32.1K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.99K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 33.1K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.04M USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.54K USD
Operating Lease, Payments 7.84K USD
Additional Paid in Capital 54.1M USD +0.04%